About Roger Jeffs
Roger Jeffs is a chief executive officer and director at Liquidia.
Form D filings name Roger Jeffs as a director at Kriya Therapeutics.
Roger Jeffs reports to the SEC as a director or officer of 7 public companies, including Axsome Therapeutics (AXSM), Albireo Pharma (ALBO) and Dova Pharmaceuticals (DOVA).
Roger Jeffs first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Roger Jeffs in the role, so the role may have started earlier or lasted longer.
LC
Liquidia Corp
Chief Executive Officer and director
2020 – 2026 · Public company (LQDA)
AI
Axsome Therapeutics, Inc.
Director
2015 – 2026 · Public company (AXSM)
AI
Albireo Pharma, Inc.
Director
2017 – 2021 · Public company (ALBO)
DI
Dova Pharmaceuticals Inc.
Director
2017 – 2019 · Public company (DOVA)
SI
Sio Gene Therapies Inc.
Director
2018 – 2019 · Public company (SIOX)
SI
Sangamo Therapeutics, Inc.
Director
2017 – 2018 · Public company (SGMO)
UC
United Therapeutics Corp.
President & Co-CEO, director
2006 – 2016 · Public company (UTHR)
Key Colleagues at Startups
The people Roger Jeffs works with at each company, as listed on that company's latest Form D.
Kriya Therapeutics, Inc. · Form D/A, Sep 10, 2025
NV
Neelaksh Varshney
Director
MS
Michele Stone
Executive officer
IO
Ilan Oren
Director
SR
Saira Ramasastry
Director
RG
Ryan Gallagher
Director
KM
Keith Manchester
Director
KE
Katherine Eade
Executive officer
JM
James Momtazee
Director
AR
Akshay Rai
Director
SR
Shankar Ramaswamy
Chief Executive Officer and director
CH
Curt Herberts
Executive officer
BP
Britt Petty
Executive officer
BF
Brian Furmanski
Executive officer
TG
Trit Garg
Director